SI
SI
discoversearch

 Biotech / Medical | MultiCell Technologies, Inc.


Previous 10 | Next 10 
From: jimpit4/3/2011 12:46:50 PM
   of 228
 
The New York Times
Sunday, April 3, 2011

Business > Companies > MultiCell Technologies Inc.

MultiCell Technologies Inc.
MCET: OTC Bulletin Board Market; Healthcare/Pharmaceuticals - Diversified

topics.nytimes.com

_________________________________________________________________

Jim

.

Share Recommend | Keep | Reply | Mark as Last Read


From: jimpit5/31/2011 6:22:47 PM
   of 228
 
MultiCell Technologies is Granted Stem Cell Patent...!

MultiCell Technologies is Granted Stem Cell Patent
Press Release Source: MultiCell Technologies, Inc.
Tuesday May 31, 2011, 8:30 am EDT

"WOONSOCKET, R.I., May 31, 2011 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board:MCET.ob - News) is pleased to announce the issuance of U.S. patent 7,935,528 by the United States Patent and Trademark Office (USPTO) relating to the isolation and use of human liver stem cells to treat liver disease. Under the terms of its license agreement with Rhode Island Hospital, MultiCell Technologies is the worldwide exclusive licensee of U.S. patent 7,935,528..."

-MORE-
finance.yahoo.com

__________________________________________________________________

Jim

.

Share Recommend | Keep | Reply | Mark as Last Read


From: jimpit6/1/2011 11:13:51 AM
   of 228
 
MultiCell Technologies Headlines as Stock in Focus on MicroStockProfit.com


MultiCell Technologies Headlines as Stock in Focus on MicroStockProfit.com
Press Release Source: MicroStockProfit.com
Wednesday June 1, 2011, 6:50 am EDT

finance.yahoo.com

_________________________________________________________________

Jim

.

Share Recommend | Keep | Reply | Mark as Last Read


From: jimpit6/2/2011 11:08:48 AM
   of 228
 
Insight on MultiCell Technologies, Inc. and Aradigm Corporation

New Demand & Necessity Buoy Industry -- Insight on MultiCell Technologies, Inc. and Aradigm Corporation
Press Release Source: Global Equity Reporter
Thursday June 2, 2011, 9:00 am EDT

finance.yahoo.com

______________________________________________________________

Jim

.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)


To: jimpit who wrote (216)6/6/2011 12:05:52 AM
From: nocpimping
   of 228
 
MCET..Showed very strong support above the .01 area. We should see an uptrend from here...

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)


To: nocpimping who wrote (217)6/8/2011 7:06:54 PM
From: jimpit
   of 228
 
Hope so!

Some of us have been patiently waiting for years!

GLTA,
Jim

Share Recommend | Keep | Reply | Mark as Last Read


From: jimpit7/11/2011 9:38:19 AM
   of 228
 
MultiCell and University Health Network Will Evaluate Two Potential Therapies for Liver Cancer Treatment

MultiCell and University Health Network Will Evaluate Two Potential Therapies for Liver Cancer Treatment
SOURCE MultiCell Technologies, Inc.
WOONSOCKET, R.I., July 11, 2011
PRNewswire

prnewswire.com

_____________________________________________________________________

Jim

.

Share Recommend | Keep | Reply | Mark as Last Read


From: Shawn Donahue7/11/2011 11:27:41 AM
   of 228
 
si.advfn.com

Item 1.01 Entry Into a Material Definitive Agreement.


On July 5, 2011, MultiCell Technology, Inc., or the Company, entered into a sponsored research agreement with the University Health Network, or UHN, a not - for - profit corporation incorporated under the laws of Canada. Under this agreement UHN will evaluate the Company’s product candidates, MCT-465 and MCT-485, in in vitro models for the treatment of primary liver cancer. The mechanism of action of MCT-465 and MCT-485 and their potential selective effect on liver cancer stem cells will also be evaluated. Under the terms of the agreement, the Company will retain exclusive access to the research findings and intellectual property resulting from the research activities preformed by UHN. The foregoing description of the agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the agreement, a copy of which is attached hereto as Exhibit 10.1 to this current report on Form 8-K.


Item 8.01 Other Events.


On July 11, 2011, the Company issued a press release announcing that the Company entered into the above reference sponsored research agreement with UHN. The text of the press release is included as Exhibit 99.1 to this current report on Form 8-K.


The information and exhibit to this Item 8.01 shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, or the Exchange Act, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, or the Exchange Act, except to the extent that we specifically incorporate it by reference.


Item 9.01 Exhibits



Exhibit No. Description

10.1 Sponsored Research Agreement, dated as of July 5, 2011, by and between MultiCell Technologies, Inc., and University Health Network. +

99.1 Press Release dated July 11, 2011.

+ Portions of this exhibit have been omitted pursuant to a request for confidential treatment and the non-public information has been filed separately with the SEC.





--------------------------------------------------------------------------------




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


MULTICELL TECHNOLOGIES, INC.

By: /s/ W. Gerald Newmin
W. Gerald Newmin
Chief Executive Officer, Chief Financial Officer



Date: July 11, 2011

Share Recommend | Keep | Reply | Mark as Last Read


From: jimpit8/5/2011 2:59:07 PM
   of 228
 
MultiCell Technology and Aastrom Biosciences Aim to Shatter Stem Cell Myths


MultiCell Technology and Aastrom Biosciences Aim to Shatter Stem Cell Myths
SOURCE: The Bedford Report
Marketwire - August 05, 2011 08:16 ET

The Bedford Report Provides Equity Research on MultiCell Technologies and Aastrom Biosciences

marketwire.com

______________________________________________________________________________

Jim

.

Share Recommend | Keep | Reply | Mark as Last Read


From: jimpit1/3/2012 10:58:37 PM
   of 228
 
MultiCell Technologies Receives Final Payment Under QTDP Program

MultiCell Technologies Receives Final Payment Under QTDP Program

"WOONSOCKET, R.I., Jan. 3, 2012 /PRNewswire/ 08:30 ET -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has received the final cash grant award payment of $303,102 under the U.S. Government's Qualifying Therapeutic Discovery Project ("QTDP") program. The QTDP program was created by Congress as part of the Patient Protection and Affordable Care Act, and provides a tax credit or cash grant equal to eligible costs and expenses..."

(more)
prnewswire.com

____________________________________________________________________________

Jim

.

Share Recommend | Keep | Reply | Mark as Last Read
Previous 10 | Next 10 

Copyright © 1995-2014 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.